Are Wall Street Analysts Predicting Becton, Dickinson, and Company Stock Will Climb or Sink?

Becton, Dickinson, and Company (BDX), headquartered in Franklin Lakes, New Jersey, is a medical technology company that develops, manufactures, and sells medical devices, medical supplies, laboratory equipment, and diagnostic products. Valued at $68.2 billion by market cap, the company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.

Shares of this medical instrument maker have struggled to keep up with the broader market over the past year. BDX stock has plunged 13.8% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 28.3%. In 2024, BDX stock is down 3.3%, while the SPX is up 17.6% on a YTD basis.